Sudeep Pharma Closes Trading Window for Q1 FY27 Results

Sudeep Pharma Limited has announced the closure of its trading window for designated persons and their immediate relatives, effective July 1, 2026. This closure is in anticipation of the adoption of the un-audited financial results for the quarter ending June 30, 2026. The trading window will remain shut until 48 hours after the declaration of these financial results. The company will inform stock exchanges about the board meeting date for approving these results in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading.